Top

Published in:

01-12-2020 | Antibiotic | Research

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia

Authors: Nathan Peiffer-Smadja, Lila Bouadma, Vincent Mathy, Kahina Allouche, Juliette Patrier, Martin Reboul, Philippe Montravers, Jean-François Timsit, Laurence Armand-Lefevre

Published in: Critical Care | Issue 1/2020

Abstract

Background

Early appropriate antibiotic therapy reduces morbidity and mortality of severe pneumonia. However, the emergence of bacterial resistance requires the earliest use of antibiotics with the narrowest possible spectrum. The Unyvero Hospitalized Pneumonia (HPN, Curetis) test is a multiplex PCR (M-PCR) system detecting 21 bacteria and 19 resistance genes on respiratory samples within 5 h. We assessed the performance and the potential impact of the M-PCR on the antibiotic therapy of ICU patients.

Methods

In this prospective study, we performed a M-PCR on bronchoalveolar lavage (BAL) or plugged telescoping catheter (PTC) samples of patients with ventilated HAP or VAP with Gram-negative bacilli or clustered Gram-positive cocci. This study was conducted in 3 ICUs in a French academic hospital: the medical and infectious diseases ICU, the surgical ICU, and the cardio-surgical ICU. A multidisciplinary expert panel simulated the antibiotic changes they would have made if the M-PCR results had been available.

Results

We analyzed 95 clinical samples of ventilated HAP or VAP (72 BAL and 23 PTC) from 85 patients (62 males, median age 64 years). The median turnaround time of the M-PCR was 4.6 h (IQR 4.4–5). A total of 90/112 bacteria were detected by the M-PCR system with a global sensitivity of 80% (95% CI, 73–88%) and specificity of 99% (95% CI 99–100). The sensitivity was better for Gram-negative bacteria (90%) than for Gram-positive cocci (62%) (p = 0.005). Moreover, 5/8 extended-spectrum beta-lactamases (CTX-M gene) and 4/4 carbapenemases genes (3 NDM, one oxa-48) were detected. The M-PCR could have led to the earlier initiation of an effective antibiotic in 20/95 patients (21%) and to early de-escalation in 37 patients (39%) but could also have led to one (1%) inadequate antimicrobial therapy. Among 17 empiric antibiotic treatments with carbapenems, 10 could have been de-escalated in the following hours according to the M-PCR results. The M-PCR also led to 2 unexpected diagnosis of severe legionellosis confirmed by culture methods.

Conclusions

Our results suggest that the use of a M-PCR system for respiratory samples of patients with VAP and ventilated HAP could improve empirical antimicrobial therapy and reduce the use of broad-spectrum antibiotics.

Available only for authorised users

Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. https://doi.org/10.1093/cid/ciw353.CrossRefPubMedPubMedCentral

Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care–associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732–44. https://doi.org/10.1056/NEJMoa1801550.CrossRefPubMed

Ibn Saied W, Mourvillier B, Cohen Y, et al. A comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia. Crit Care Med. 2019;47(3):345–52. https://doi.org/10.1097/CCM.0000000000003553.CrossRefPubMed

Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT) Eur Respir J. 2017;50(3). doi:https://doi.org/10.1183/13993003.00582-2017.

Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010;51(Suppl 1):S81–7. https://doi.org/10.1086/653053.CrossRefPubMed

Kollef MH, Bassetti M, Francois B, et al. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017;43(9):1187–97. https://doi.org/10.1007/s00134-017-4682-7.CrossRefPubMedPubMedCentral

Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria. Curr Opin Crit Care. 2018;24(5):385–93. https://doi.org/10.1097/MCC.0000000000000534.CrossRefPubMed

Bergmans DC, Bonten MJ, Gaillard CA, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother. 1997;39(4):527–35. https://doi.org/10.1093/jac/39.4.527.CrossRefPubMed

Barbier F, Andremont A, Wolff M, Bouadma L. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Curr Opin Pulm Med. 2013;19(3):216–28. https://doi.org/10.1097/MCP.0b013e32835f27be.CrossRefPubMed

10.

Armand-Lefèvre L, Angebault C, Barbier F, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013;57(3):1488–95. https://doi.org/10.1128/AAC.01823-12.CrossRefPubMedPubMedCentral

11.

Timsit J-F, Bassetti M, Cremer O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45(2):172–89. https://doi.org/10.1007/s00134-019-05520-5.CrossRefPubMed

12.

Le Dorze M, Gault N, Foucrier A, et al. Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia. Clin Microbiol Infect. 2015;21(5):468.e1–6. https://doi.org/10.1016/j.cmi.2014.12.007.CrossRef

13.

Huang H-S, Tsai C-L, Chang J, Hsu T-C, Lin S, Lee C-C. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clin Microbiol Infect. 2018;24(10):1055–63. https://doi.org/10.1016/j.cmi.2017.11.018.CrossRefPubMed

14.

Jamal W, Al Roomi E, AbdulAziz LR, Rotimi VO. Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia. J Clin Microbiol. 2014;52(7):2487–92. https://doi.org/10.1128/JCM.00325-14.CrossRefPubMedPubMedCentral

15.

Timsit J-F, Esaied W, Neuville M, Bouadma L, Mourvillier B. Update on ventilator-associated pneumonia. F1000Res. 2017;6. https://doi.org/10.12688/f1000research.12222.1.

16.

Weiss E, Zahar J-R, Lesprit P, et al. Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams. Clin Microbiol Infect. 2015;21(7):649.e1–10. https://doi.org/10.1016/j.cmi.2015.03.013.CrossRef

17.

Mizrahi A, Delerue T, Morel H, et al. Infections caused by naturally AmpC-producing Enterobacteriaceae: can we use third-generation cephalosporins? A narrative review. Int J Antimicrob Agents. 2020;55(2):105834. https://doi.org/10.1016/j.ijantimicag.2019.10.015.CrossRefPubMed

18.

Papan C, Meyer-Buehn M, Laniado G, Nicolai T, Griese M, Huebner J. Assessment of the multiplex PCR-based assay Unyvero pneumonia application for detection of bacterial pathogens and antibiotic resistance genes in children and neonates. Infection. 2018;46(2):189–96. https://doi.org/10.1007/s15010-017-1088-y.CrossRefPubMed

19.

Ozongwu C, Personne Y, Platt G, et al. The Unyvero P55 “sample-in, answer-out” pneumonia assay: a performance evaluation. Biomol Detect Quantification. 2017;13:1–6. https://doi.org/10.1016/j.bdq.2017.06.001.CrossRef

20.

Schulte B, Eickmeyer H, Heininger A, et al. Detection of pneumonia associated pathogens using a prototype multiplexed pneumonia test in hospitalized patients with severe pneumonia. PLoS One. 2014;9(11):e110566. https://doi.org/10.1371/journal.pone.0110566.CrossRefPubMedPubMedCentral

21.

Kunze N, Moerer O, Steinmetz N, Schulze MH, Quintel M, Perl T. Point-of-care multiplex PCR promises short turnaround times for microbial testing in hospital-acquired pneumonia–an observational pilot study in critical ill patients. Ann Clin Microbiol Antimicrob. 2015;14:33. https://doi.org/10.1186/s12941-015-0091-3.CrossRefPubMedPubMedCentral

22.

Personne Y, Ozongwu C, Platt G, et al. “Sample-in, answer-out”? Evaluation and comprehensive analysis of the Unyvero P50 pneumonia assay. Diagn Microbiol Infect Dis. 2016;86(1):5–10. https://doi.org/10.1016/j.diagmicrobio.2016.06.010.CrossRefPubMed

23.

La Combe B, Clermont O, Messika J, et al. Pneumonia-specific Escherichia coli with distinct phylogenetic and virulence profiles, France, 2012-2014. Emerg Infect Dis. 2019;25(4):710–8. https://doi.org/10.3201/eid2504.180944.CrossRefPubMedPubMedCentral

24.

Harris PNA, Tambyah PA, Lye DC, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984–94. https://doi.org/10.1001/jama.2018.12163.CrossRefPubMedPubMedCentral

25.

Ofer-Friedman H, Shefler C, Sharma S, et al. Carbapenems versus piperacillin-tazobactam for bloodstream infections of nonurinary source caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol. 2015;36(8):981–5. https://doi.org/10.1017/ice.2015.101.CrossRefPubMed

26.

Harris PNA, Tambyah PA, Paterson DL. β-Lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? Lancet Infect Dis. 2015;15(4):475–85. https://doi.org/10.1016/S1473-3099(14)70950-8.CrossRefPubMed

27.

Tamma PD, Han JH, Rock C, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. Clin Infect Dis. 2015;60(9):1319–25. https://doi.org/10.1093/cid/civ003.CrossRefPubMedPubMedCentral

28.

Retamar P, López-Cerero L, Muniain MA, Pascual Á, Rodríguez-Baño J, ESBL-REIPI/GEIH Group. Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli. Antimicrob Agents Chemother 2013;57(7):3402–3404. doi:https://doi.org/10.1128/AAC.00135-13.

29.

Collins ME, Popowitch EB, Miller MB. Evaluation of a novel multiplex PCR panel compared to quantitative bacterial culture for the diagnosis of lower respiratory tract infections. J Clin Microbiol Published online February 19. 2020. https://doi.org/10.1128/JCM.02013-19.

30.

Poritz MA, Blaschke AJ, Byington CL, et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One. 2011;6(10):e26047. https://doi.org/10.1371/journal.pone.0026047.CrossRefPubMedPubMedCentral

31.

Trotter AJ, Aydin A, Strinden MJ, O’Grady J. Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance. Curr Opin Microbiol. 2019;51:39–45. https://doi.org/10.1016/j.mib.2019.03.001.CrossRefPubMed

32.

Chiu CY, Miller SA. Clinical metagenomics. Nat Rev Genet. 2019;20(6):341–55. https://doi.org/10.1038/s41576-019-0113-7.CrossRefPubMedPubMedCentral

33.

Peiffer-Smadja N, Dellière S, Rodriguez C, et al. Machine learning in the clinical microbiology laboratory: has the time come for routine practice? Clin Microbiol Infect Published online February 12. 2020. https://doi.org/10.1016/j.cmi.2020.02.006.

34.

Bauer KA, Perez KK, Forrest GN, Goff DA. Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis. 2014;59(suppl_3):S134–45. https://doi.org/10.1093/cid/ciu547.CrossRefPubMed

35.

Sircar M, Ranjan P, Gupta R, et al. Impact of bronchoalveolar lavage multiplex polymerase chain reaction on microbiological yield and therapeutic decisions in severe pneumonia in intensive care unit. J Crit Care. 2016;31(1):227–32. https://doi.org/10.1016/j.jcrc.2015.10.012.CrossRefPubMed

36.

Banerjee R, Teng CB, Cunningham SA, et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61(7):1071–80. https://doi.org/10.1093/cid/civ447.CrossRefPubMedPubMedCentral

37.

Özenci V, Rossolini GM. Rapid microbial identification and antimicrobial susceptibility testing to drive better patient care: an evolving scenario. J Antimicrob Chemother. 2019;74(Supplement_1):i2–5. https://doi.org/10.1093/jac/dky529.CrossRefPubMedPubMedCentral

38.

Peiffer-Smadja N, Rawson TM, Ahmad R, et al. Machine learning for clinical decision support in infectious diseases: a narrative review of current applications. Clin Microbiol Infect Published online September 17. 2019. https://doi.org/10.1016/j.cmi.2019.09.009.

Title: Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
Authors: Nathan Peiffer-Smadja
Lila Bouadma
Vincent Mathy
Kahina Allouche
Juliette Patrier
Martin Reboul
Philippe Montravers
Jean-François Timsit
Laurence Armand-Lefevre
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Antibiotic
Carbapenem Antibiotic
Nosocomial Pneumonia
Pneumonia
Published in: Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-020-03067-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?

Significance of body temperature in elderly patients with sepsis

Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis

Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!

A simple custom appliance against droplet and aerosol transmission of COVID-19 during advanced airway management

Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients